SUBSCRIBE
SUBSCRIBE

Vertex Pharmaceuticals

NEWS
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
BioCapital
Analysts Say FDA’s AdCom Vote on Vertex No “Slam Dunk,” But Should be Enough for Now
May 12, 2015
 · 
4 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Policy
Vertex Soars After Hours as FDA Panel Backs Cystic Fibrosis Drug Orkambi
May 12, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Investors Hold Their Breath as Vertex Defends Newly Branded Cystic Fibrosis Treatment to the FDA
May 12, 2015
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Heart-Stopping Morning Leads to Vertex Rise As FDA News Sees Positives
May 8, 2015
 · 
3 min read
Biotech Bay
Why Gilead Will Probably Not Rush With The Vertex Acquisition
May 5, 2015
 · 
1 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Tiny Corbus Looks to Give Vertex Some Competition With Experimental Cystic Fibrosis Drug
May 5, 2015
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Genetown
Five Things to Take Away From Vertex’s Q1
April 30, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Why a Gilead/Vertex Deal Makes More and More Sense
April 28, 2015
 · 
3 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
BioCapital
Buy Vertex Now for $45B Or Risk It All, Analyst Tells Gilead
April 21, 2015
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Vertex Pharmaceuticals (MA) Announces Presentation Of New KALYDECO™ (Ivacaftor) Data At European Cystic Fibrosis Society Conference
June 12, 2014
 · 
1 min read
Drug Development
Vertex Pharmaceuticals (MA) Trial Suggests Kalydeco May Work In More Cystic Fibrosis Patients
June 5, 2014
 · 
1 min read
Genetown
Vertex Pharmaceuticals (MA) To Present At The Goldman, Sachs & Co. Global Healthcare Conference On June 10
June 4, 2014
 · 
1 min read
Drug Development
Vertex Pharmaceuticals (MA) Reports Positive Ivacaftor Study Data, Plans To Initiate Larger Phase 3 Study
June 4, 2014
 · 
12 min read
Genetown
Vertex Pharmaceuticals (MA) To Present At The UBS Global Healthcare Conference On May 20
May 14, 2014
 · 
1 min read
Drug Development
Vertex Pharmaceuticals (MA) Release: Addition Of VX-661 To KALYDECO® (Ivacaftor) Improves Lung Function In People With CF Who Are Heterozygous For The F508del And G551D Mutations In 28-Day Phase 2 Proof-Of-Concept Study
May 2, 2014
 · 
1 min read
Business
Vertex Pharmaceuticals (MA) Reports First Quarter 2014 Financial Results And Provides Updates On Key Business Priorities
May 2, 2014
 · 
1 min read
Drug Development
One-Time Hepatitis C King Vertex Pharmaceuticals (MA) Shows Off Promising Phase 2 Cystic Fibrosis Data
May 1, 2014
 · 
11 min read
Genetown
Vertex Pharmaceuticals (MA) To Present At The Barclays Global Healthcare Conference On March 11
March 7, 2014
 · 
1 min read
FDA
FDA Approves Vertex Pharmaceuticals (MA)'s KALYDECO™ (Ivacaftor) For Use In Eight Additional Mutations That Cause Cystic Fibrosis
February 24, 2014
 · 
9 min read
Load More